Natural Capsules logo

Natural Capsules

NATCAPSUQ NSE
₹136.44 7.13 (4.97%)
Market Cap
₹142 Cr

Natural Capsules (NATCAPSUQ) share price was ₹136.44 at the 28 Oct 2026 close; market capitalisation ₹142 Cr; sector Healthcare. The share price fell 37.2% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 7.8% year on year to ₹48.71 Cr and net profit was −₹5.75 Cr, against −₹5.58 Cr a year earlier (compared with Jun 2025). Promoters held 50.92% of Natural Capsules in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 47/100 (Average) as of 28 Oct 2026.

Close 28 Oct 2026 ₹136.44 −80.86 −37.21% 1Y

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare
Market Cap
₹142 Cr
EBITDA
₹20.00 L
Return on Equity
-10.51%
Debt to Equity
0.93
Book Value
₹168.08
EPS (TTM)
−₹18.67
52W High
₹234.00
52W Low
₹135.60

Price-based figures as of 28 Oct 2026, 15:31 IST · EPS basis: Consolidated · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,757.5034.864,21,683 Cr5.050.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,558.5086.752,53,748 Cr15.140.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,557.0071.541,73,334 Cr9.430.82%12.16%9.06%17,058 Cr2,156 Cr
Laurus Labs
₹2,181.90107.801,17,891 Cr22.240.09%16.38%19.67%7,323 Cr1,090 Cr
Zydus Life Science
₹1,175.5026.161,17,257 Cr4.330.09%16.99%19.24%28,515 Cr4,593 Cr
Dr Reddys Laboratories
₹1,335.4034.591,11,463 Cr2.870.61%10.87%13.94%34,247 Cr3,184 Cr
Cipla
₹1,365.6032.721,10,321 Cr3.120.96%11.21%14.88%28,589 Cr3,356 Cr
Natural Capsules (this company)
₹136.44—142 Cr0.810.70%-10.51%-5.82%195 Cr-25 Cr
Median 8 companies₹1,561.5534.861,17,574 Cr4.690.66%12.98%16.41%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100. How it works →

As of 2026-10-28
v2.0.0
47 Average
Overall score
Data confidence 93/100

Category scores

Quality Average 52
Returns, margins, earnings quality 22%
Valuation Average 50
Cheap vs sector & own history 24%
Growth Average 50
Sales & profit trajectory 9%
Financial Health Poor 14
Solvency, leverage, coverage 9%
Momentum Poor 32
Trend strength, vol-adjusted 12%
Ownership Average 52
FII/DII/promoter flows 24%

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Stock is trading at 0.98 times its book value

Weaknesses

6
  • Company has low interest coverage ratio.
  • Company has a low return on equity of -2.06% over last 3 years.
  • Contingent liabilities of Rs.75.2 Cr.
  • Company might be capitalizing the interest cost
  • Earnings include an other income of Rs.3.72 Cr.
  • Promoter holding has decreased over last 3 years: -5.65%

Technical Indicators

Oscillators

BearishNeutralBullish

Bullish

Bearish
2
Neutral
2
Bullish
5

Overall

BearishNeutralBullish

Bearish

Bearish
12
Neutral
2
Bullish
5

Moving Averages

BearishNeutralBullish

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
11.18% higher than 3Y

change over 1 year

Net Income Growth
—

Cash Flow Change
-59.18%

change over 1 year

EBITDA Margin Change
-99.16%

change over 1 year Operating margin 2.3% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
37.7
37.52
39.98
40.22
39.18
41.22
43.83
44.97
45.2
45.8
37.75
58.45
48.71
Expenses
31.74
32.4
35.26
36.11
34.81
36.72
39.56
40.58
44.88
46.69
40.07
57.12
47.59
Operating Profit
5.96
5.12
4.72
4.11
4.37
4.5
4.27
4.39
0.32
-0.89
-2.32
1.33
1.12
OPM %
15.81%
13.65%
11.81%
10.22%
11.15%
10.92%
9.74%
9.76%
0.71%
-1.94%
-6.15%
2.28%
2.3%
Other Income
0.17
0.35
0.5
0.92
0.18
0.11
0.11
0.3
0.36
0.16
0.45
0.76
2.35
Interest
1.33
1.16
1.24
1.4
1.49
1.65
1.54
1.64
2.53
2.68
2.85
2.89
4.97
Depreciation
2.11
2.17
2.19
2.2
2.28
2.35
2.33
2.16
4.21
4.29
4.36
4.28
4.33
PBT
2.69
2.14
1.79
1.43
0.78
0.61
0.51
0.89
-6.06
-7.7
-9.08
-5.08
-5.83
Tax %
32.34%
27.1%
32.96%
32.17%
21.79%
201.64%
78.43%
41.57%
-8.09%
-9.09%
-21.7%
-1.97%
-1.54%
Net Profit
1.82
1.56
1.21
0.97
0.6
-0.61
0.11
0.52
-5.58
-6.99
-7.12
-4.98
-5.75
EPS (₹)
1.96
1.68
1.3
1.04
0.64
-0.6
0.11
0.35
-5.4
-6.76
-4.77
-3.32
-3.82
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
55
60
62
80
135
170
155
169
187
191
Expenses
49
55
56
68
110
135
135
151
188
191
Operating Profit
6
5
5
11
26
35
20
18
-1
-1
OPM %
10%
8%
9%
14%
19%
21%
13%
10%
-0.5%
-0.4%
Other Income
1
1
1
3
1
1
2
1
2
4
Interest
0
1
1
1
2
4
5
7
12
13
Depreciation
4
3
4
4
5
7
9
9
17
17
PBT
2
2
1
9
19
25
8
3
-28
-28
Tax %
34%
7%
38%
24%
28%
26%
31%
78%
-12%
—
Net Profit
1
2
1
7
14
18
6
1
-25
-25
EPS (₹)
1.19
2.06
0.92
7.43
14.96
20.02
5.95
0.42
-16.44
-18.67
Div. Payout %
56%
32%
43%
9%
5%
5%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
6
6
6
6
7
9
9
10
10
Reserves
48
49
49
56
76
114
194
176
165
Borrowings
0
5
6
10
53
97
109
152
162
Other Liabilities
19
14
14
27
29
70
64
81
87
Total Liabilities
73
75
76
99
165
290
377
419
424
Fixed Assets
22
24
24
38
66
97
103
284
274
CWIP
1
2
2
7
20
88
144
0
4
Investments
5
5
6
0
0
0
3
3
3
Other Assets
45
43
45
54
79
105
127
133
143
Total Assets
73
75
76
99
165
290
377
419
424
Figures in ₹ Crores

Cash Flow

Particulars Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
5
2
7
13
-1
17
-8
27
11
Investing
-1
-7
-6
-16
-46
-105
-73
-44
-11
Financing
-4
4
-1
3
48
87
82
16
-1
Net Cash Flow
0
-1
0
0
1
0
1
-2
0
Free Cash Flow
4
-5
2
-11
-47
-88
-79
-18
-1
CFO/OP
97
57
144
134
17
64
-32
162
-1,634
Figures in ₹ Crores

Ratios

Particulars Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
208
197
180
123
71
112
128
134
139
Inventory Days
149
87
89
82
34
45
88
109
94
Days Payable
185
114
91
159
98
127
141
166
197
Cash Conversion Cycle
172
170
179
45
7
30
75
78
36
Working Capital Days
186
143
121
35
73
61
80
53
-1
ROCE %
—
5%
4%
11%
21%
15%
5%
3%
-5%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Natural Capsules insights

70 extracted metrics + investor summaries across FY07–FY27.

Shareholding Pattern

FIIs0.08%Promot.50.92%Others15.62%Public33.38%As ofSep 2026

Documents

Frequently Asked Questions about Natural Capsules

What does Natural Capsules Ltd do?
Incorporated in 1993, Natural Capsules manufactures Capsules and Steroidal APIs and their Intermediates and Derivatives[1]
Where is Natural Capsules Ltd (NATCAPSUQ) listed?
Natural Capsules Ltd trades as NATCAPSUQ on the NSE and under code 524654 on the BSE.
Which sector does Natural Capsules Ltd belong to?
Natural Capsules Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Natural Capsules Ltd?
Natural Capsules Ltd has a market capitalisation of ₹142.05 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Natural Capsules Ltd?
Over the last 52 weeks Natural Capsules Ltd has traded between ₹135.6 and ₹234 as of 28 Oct 2026.
Does Natural Capsules Ltd pay dividends?
Natural Capsules Ltd has a dividend yield of 0.70%.
What is the Return on Equity (ROE) of Natural Capsules Ltd?
Natural Capsules Ltd reported a return on equity of -10.51%. Its debt-to-equity ratio is 0.93.

Company Information

Incorporated in 1993, Natural Capsules manufactures Capsules and Steroidal APIs and their Intermediates and Derivatives[1]

Website naturalcapsules.com
CEO Mr. Sunil Laxminarayana Kumar Mundra
Employees 619
Listed 2025-02-14
Face Value ₹ 10
Shares Outstanding 1,04,11,154

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/NATCAPSUQ.md for Natural Capsules Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month